BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Taura M, Fukuda R, Suico MA, Eguma A, Koga T, Shuto T, Sato T, Morino-Koga S, Kai H. TLR3 induction by anticancer drugs potentiates poly I:C-induced tumor cell apoptosis. Cancer Sci 2010;101:1610-7. [PMID: 20367642 DOI: 10.1111/j.1349-7006.2010.01567.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 4.1] [Reference Citation Analysis]
Number Citing Articles
1 Hu X, Zou H, Qin A, Qian K, Shao H, Ye J. Activation of Toll-like receptor 3 inhibits Marek's disease virus infection in chicken embryo fibroblast cells. Arch Virol 2016;161:521-8. [PMID: 26597188 DOI: 10.1007/s00705-015-2674-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
2 Bianchi F, Pretto S, Tagliabue E, Balsari A, Sfondrini L. Exploiting poly(I:C) to induce cancer cell apoptosis. Cancer Biol Ther 2017;18:747-56. [PMID: 28881163 DOI: 10.1080/15384047.2017.1373220] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 9.2] [Reference Citation Analysis]
3 Goutagny N, Estornes Y, Hasan U, Lebecque S, Caux C. Targeting pattern recognition receptors in cancer immunotherapy. Target Oncol 2012;7:29-54. [PMID: 22399234 DOI: 10.1007/s11523-012-0213-1] [Cited by in Crossref: 65] [Cited by in F6Publishing: 60] [Article Influence: 6.5] [Reference Citation Analysis]
4 Matijević T, Kirinec G, Pavelić J. Antitumor activity from the combined application of poly(I:C) and chemotherapeutics in human metastatic pharyngeal cell lines. Chemotherapy 2011;57:460-7. [PMID: 22188667 DOI: 10.1159/000334122] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
5 Pahlavanneshan S, Sayadmanesh A, Ebrahimiyan H, Basiri M. Toll-Like Receptor-Based Strategies for Cancer Immunotherapy. J Immunol Res 2021;2021:9912188. [PMID: 34124272 DOI: 10.1155/2021/9912188] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Shatz M, Menendez D, Resnick MA. The human TLR innate immune gene family is differentially influenced by DNA stress and p53 status in cancer cells. Cancer Res 2012;72:3948-57. [PMID: 22673234 DOI: 10.1158/0008-5472.CAN-11-4134] [Cited by in Crossref: 87] [Cited by in F6Publishing: 64] [Article Influence: 8.7] [Reference Citation Analysis]
7 Hossam N, Matboli M, Shehata HH, Aboelhussein MM, Hassan MK, Eissa S. Toll-like receptor immune modulatory role in personalized management of colorectal cancer, review of literature. Expert Review of Precision Medicine and Drug Development 2020;5:455-68. [DOI: 10.1080/23808993.2020.1816136] [Reference Citation Analysis]
8 do Prado SBR, Castro-Alves VC, Ferreira GF, Fabi JP. Ingestion of Non-digestible Carbohydrates From Plant-Source Foods and Decreased Risk of Colorectal Cancer: A Review on the Biological Effects and the Mechanisms of Action. Front Nutr 2019;6:72. [PMID: 31157230 DOI: 10.3389/fnut.2019.00072] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
9 Zhao X, Ai M, Guo Y, Zhou X, Wang L, Li X, Yao C. Poly I:C-induced tumor cell apoptosis mediated by pattern-recognition receptors. Cancer Biother Radiopharm 2012;27:530-4. [PMID: 23062195 DOI: 10.1089/cbr.2012.1226] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
10 Feng Y, Chen Y, Meng Y, Cao Q, Liu Q, Ling C, Wang C. Bufalin Suppresses Migration and Invasion of Hepatocellular Carcinoma Cells Elicited by Poly (I:C) Therapy. Oncoimmunology 2018;7:e1426434. [PMID: 29721392 DOI: 10.1080/2162402X.2018.1426434] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
11 Chen L, Yu J. Modulation of Toll-like receptor signaling in innate immunity by natural products. Int Immunopharmacol 2016;37:65-70. [PMID: 26899347 DOI: 10.1016/j.intimp.2016.02.005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
12 Amarante MK, Watanabe MA. Toll-like receptor 3: involvement with exogenous and endogenous RNA. Int Rev Immunol 2010;29:557-73. [PMID: 21073327 DOI: 10.3109/08830185.2010.525723] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
13 Glaffig M, Stergiou N, Schmitt E, Kunz H. Immunogenicity of a Fully Synthetic MUC1 Glycopeptide Antitumor Vaccine Enhanced by Poly(I:C) as a TLR3-Activating Adjuvant. ChemMedChem 2017;12:722-7. [PMID: 28440596 DOI: 10.1002/cmdc.201700254] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
14 Forghani P, Waller EK. Poly (I: C) modulates the immunosuppressive activity of myeloid-derived suppressor cells in a murine model of breast cancer. Breast Cancer Res Treat 2015;153:21-30. [PMID: 26208484 DOI: 10.1007/s10549-015-3508-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
15 Baxevanis CN, Voutsas IF, Tsitsilonis OE. Toll-like receptor agonists: current status and future perspective on their utility as adjuvants in improving anticancer vaccination strategies. Immunotherapy. 2013;5:497-511. [PMID: 23638745 DOI: 10.2217/imt.13.24] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
16 Matsuyama S, Moriuchi M, Suico MA, Yano S, Morino-Koga S, Shuto T, Yamanaka K, Kondo T, Araki E, Kai H. Mild electrical stimulation increases stress resistance and suppresses fat accumulation via activation of LKB1-AMPK signaling pathway in C. elegans. PLoS One 2014;9:e114690. [PMID: 25490091 DOI: 10.1371/journal.pone.0114690] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
17 Kato K, Lillehoj EP, Kim KC. MUC1 regulates epithelial inflammation and apoptosis by PolyI:C through inhibition of Toll/IL-1 receptor-domain-containing adapter-inducing IFN-β (TRIF) recruitment to Toll-like receptor 3. Am J Respir Cell Mol Biol 2014;51:446-54. [PMID: 24693944 DOI: 10.1165/rcmb.2014-0018OC] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
18 Koga T, Suico MA, Shimasaki S, Watanabe E, Kai Y, Koyama K, Omachi K, Morino-Koga S, Sato T, Shuto T, Mori K, Hino S, Nakao M, Kai H. Endoplasmic Reticulum (ER) Stress Induces Sirtuin 1 (SIRT1) Expression via the PI3K-Akt-GSK3β Signaling Pathway and Promotes Hepatocellular Injury. J Biol Chem 2015;290:30366-74. [PMID: 26499802 DOI: 10.1074/jbc.M115.664169] [Cited by in Crossref: 41] [Cited by in F6Publishing: 23] [Article Influence: 5.9] [Reference Citation Analysis]
19 Tian K, Rajendran R, Doddananjaiah M, Krstic-Demonacos M, Schwartz JM. Dynamics of DNA damage induced pathways to cancer. PLoS One 2013;8:e72303. [PMID: 24023735 DOI: 10.1371/journal.pone.0072303] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
20 Castro F, Försti A, Buch S, Kalthoff H, Krauss C, Bauer M, Egberts J, Schniewind B, Broering D, Schreiber S, Schmitt M, Hampe J, Hemminki K, Schafmayer C. TLR-3 polymorphism is an independent prognostic marker for stage II colorectal cancer. European Journal of Cancer 2011;47:1203-10. [DOI: 10.1016/j.ejca.2010.12.011] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 4.4] [Reference Citation Analysis]
21 Reilly SM, Hung CW, Ahmadian M, Zhao P, Keinan O, Gomez AV, DeLuca JH, Dadpey B, Lu D, Zaid J, Poirier B, Peng X, Yu RT, Downes M, Liddle C, Evans RM, Murphy AN, Saltiel AR. Catecholamines suppress fatty acid re-esterification and increase oxidation in white adipocytes via STAT3. Nat Metab 2020;2:620-34. [PMID: 32694788 DOI: 10.1038/s42255-020-0217-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
22 Słotwiński R, Słotwińska SM. Dysregulation of signaling pathways associated with innate antibacterial immunity in patients with pancreatic cancer. Cent Eur J Immunol 2016;41:404-18. [PMID: 28450804 DOI: 10.5114/ceji.2016.65140] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
23 Tabana Y, Okoye IS, Siraki A, Elahi S, Barakat KH. Tackling Immune Targets for Breast Cancer: Beyond PD-1/PD-L1 Axis. Front Oncol 2021;11:628138. [PMID: 33747948 DOI: 10.3389/fonc.2021.628138] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Menendez D, Shatz M, Resnick MA. Interactions between the tumor suppressor p53 and immune responses. Curr Opin Oncol 2013;25:85-92. [PMID: 23150340 DOI: 10.1097/CCO.0b013e32835b6386] [Cited by in Crossref: 73] [Cited by in F6Publishing: 52] [Article Influence: 8.1] [Reference Citation Analysis]
25 Guinn ZP, Petro TM. Interferon regulatory factor 3 plays a role in macrophage responses to interferon-γ. Immunobiology 2019;224:565-74. [PMID: 31072630 DOI: 10.1016/j.imbio.2019.04.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
26 Shin Y, Lim H, Choi BS, Kim KC, Kang C, Bae YS, Yoon CH. Highly activated p53 contributes to selectively increased apoptosis of latently HIV-1 infected cells upon treatment of anticancer drugs. Virol J 2016;13:141. [PMID: 27527606 DOI: 10.1186/s12985-016-0595-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
27 Meng X, Cui X, Shao X, Liu Y, Xing Y, Smith V, Xiong S, Macip S, Chen Y. poly(I:C) synergizes with proteasome inhibitors to induce apoptosis in cervical cancer cells. Translational Oncology 2022;18:101362. [DOI: 10.1016/j.tranon.2022.101362] [Reference Citation Analysis]
28 Kaczanowska S, Joseph AM, Davila E. TLR agonists: our best frenemy in cancer immunotherapy. J Leukoc Biol. 2013;93:847-863. [PMID: 23475577 DOI: 10.1189/jlb.1012501] [Cited by in Crossref: 188] [Cited by in F6Publishing: 175] [Article Influence: 20.9] [Reference Citation Analysis]
29 Warzée B, Mesnil C, Hober D, Caloone D, Pirottin D, Garigliany M, Desmecht D, Drion P, Journot L, Lekeux P, Bureau F, Desmet CJ. Viral induction of Zac1b through TLR3- and IRF3-dependent pathways. Molecular Immunology 2010;48:119-27. [DOI: 10.1016/j.molimm.2010.09.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
30 Menendez D, Lowe JM, Snipe J, Resnick MA. Ligand dependent restoration of human TLR3 signaling and death in p53 mutant cells. Oncotarget 2016;7:61630-42. [PMID: 27533082 DOI: 10.18632/oncotarget.11210] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
31 Hennessy C, O'Connell S, Egan LJ, McKernan DP. Inhibition of anti-viral responses in intestinal epithelial cells by epigenetic modifying drugs is mediated by a reduction in viral pattern recognition receptor expression and activity. Immunopharmacol Immunotoxicol 2019;41:527-37. [PMID: 31505962 DOI: 10.1080/08923973.2019.1661430] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
32 Amarante MK, Oda JM, Reiche EM, Morimoto HK, Aoki MN, Watanabe MA. Human endogenous RNAs: Implications for the immunomodulation of Toll-like receptor 3. Exp Ther Med 2011;2:925-9. [PMID: 22977599 DOI: 10.3892/etm.2011.303] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
33 Park JH, Jeon DI, Yoon HE, Kwon SM, Kim SA, Ahn SG, Yoon JH. Poly I:C inhibits cell proliferation and enhances the growth inhibitory effect of paclitaxel in oral sqaumous cell carcinoma. Acta Odontol Scand 2012;70:241-5. [PMID: 22181939 DOI: 10.3109/00016357.2011.640278] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
34 Chiba Y, Mizoguchi I, Mitobe K, Higuchi K, Nagai H, Nishigori C, Mizuguchi J, Yoshimoto T. IL-27 enhances the expression of TRAIL and TLR3 in human melanomas and inhibits their tumor growth in cooperation with a TLR3 agonist poly(I:C) partly in a TRAIL-dependent manner. PLoS One 2013;8:e76159. [PMID: 24155891 DOI: 10.1371/journal.pone.0076159] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
35 Wang X, Zhang Z, Cao H, Niu W, Li M, Xi X, Wang J. Human papillomavirus type 16 E6 oncoprotein promotes proliferation and invasion of non-small cell lung cancer cells through Toll-like receptor 3 signaling pathway. J Med Virol 2017;89:1852-60. [DOI: 10.1002/jmv.24845] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
36 Agupitan AD, Neeson P, Williams S, Howitt J, Haupt S, Haupt Y. P53: A Guardian of Immunity Becomes Its Saboteur through Mutation. Int J Mol Sci 2020;21:E3452. [PMID: 32414156 DOI: 10.3390/ijms21103452] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
37 Taura M, Kariya R, Kudo E, Goto H, Iwawaki T, Amano M, Suico MA, Kai H, Mitsuya H, Okada S. Comparative analysis of ER stress response into HIV protease inhibitors: lopinavir but not darunavir induces potent ER stress response via ROS/JNK pathway. Free Radic Biol Med 2013;65:778-88. [PMID: 23973637 DOI: 10.1016/j.freeradbiomed.2013.08.161] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
38 Zou H, Su R, Ruan J, Shao H, Qian K, Ye J, Yao Y, Nair V, Qin A. Double-stranded RNA induces chicken T-cell lymphoma apoptosis by TRIF and NF-κB. Sci Rep 2017;7:7547. [PMID: 28790362 DOI: 10.1038/s41598-017-07919-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
39 Andries O, Filette MD, De Smedt SC, Demeester J, Poucke MV, Peelman L, Sanders NN. Innate immune response and programmed cell death following carrier-mediated delivery of unmodified mRNA to respiratory cells. Journal of Controlled Release 2013;167:157-66. [DOI: 10.1016/j.jconrel.2013.01.033] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 4.0] [Reference Citation Analysis]
40 Shen P, Jiang T, Lu H, Han H, Luo R. Combination of Poly I:C and arsenic trioxide triggers apoptosis synergistically via activation of TLR3 and mitochondrial pathways in hepatocellular carcinoma cells. Cell Biol Int 2011;35:803-10. [PMID: 21418039 DOI: 10.1042/CBI20100739] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
41 Umemura N, Zhu J, Mburu YK, Forero A, Hsieh PN, Muthuswamy R, Kalinski P, Ferris RL, Sarkar SN. Defective NF-κB signaling in metastatic head and neck cancer cells leads to enhanced apoptosis by double-stranded RNA. Cancer Res 2012;72:45-55. [PMID: 22058147 DOI: 10.1158/0008-5472.CAN-11-1484] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
42 Saliev T, Feril LB, Begimbetova D, Baiskhanova D, Klodzinskyi A, Bobrova X, Aipov R, Baltabayeva T, Tachibana K. Hyperthermia enhances bortezomib-induced apoptosis in human white blood cancer cells. Journal of Thermal Biology 2017;67:9-14. [DOI: 10.1016/j.jtherbio.2017.04.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
43 Javaid N, Choi S. Toll-like Receptors from the Perspective of Cancer Treatment. Cancers (Basel) 2020;12:E297. [PMID: 32012718 DOI: 10.3390/cancers12020297] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
44 Taura M, Suico MA, Koyama K, Komatsu K, Miyakita R, Matsumoto C, Kudo E, Kariya R, Goto H, Kitajima S, Takahashi C, Shuto T, Nakao M, Okada S, Kai H. Rb/E2F1 regulates the innate immune receptor Toll-like receptor 3 in epithelial cells. Mol Cell Biol 2012;32:1581-90. [PMID: 22310660 DOI: 10.1128/MCB.06454-11] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
45 Ramani M, Nguyen TDT, Aryal S, Ghosh KC, Delong RK. Elucidating the RNA Nano–Bio Interface: Mechanisms of Anticancer Poly I:C RNA and Zinc Oxide Nanoparticle Interaction. J Phys Chem C 2017;121:15702-10. [DOI: 10.1021/acs.jpcc.7b02954] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 2.4] [Reference Citation Analysis]
46 Marei HE, Althani A, Afifi N, Hasan A, Caceci T, Pozzoli G, Morrione A, Giordano A, Cenciarelli C. p53 signaling in cancer progression and therapy. Cancer Cell Int 2021;21:703. [PMID: 34952583 DOI: 10.1186/s12935-021-02396-8] [Reference Citation Analysis]
47 Moradi-Marjaneh R, Hassanian SM, Fiuji H, Soleimanpour S, Ferns GA, Avan A, Khazaei M. Toll like receptor signaling pathway as a potential therapeutic target in colorectal cancer. J Cell Physiol 2018;233:5613-22. [PMID: 29150944 DOI: 10.1002/jcp.26273] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]